You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 126 No. 11, November 2000 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Article
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (7)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Bacterial Infections
 •Otolaryngology/ Head & Neck Surgery, Other
 •Rheumatology, Other
 •Infectious Diseases
 •Alert me on articles by topic

Fewer Symptoms Occur in Same-Serotype Recurrent Streptococcal Tonsillopharyngitis

Lucia H. Lee, MD; Elia Ayoub, MD; Michael E. Pichichero, MD

Arch Otolaryngol Head Neck Surg. 2000;126:1359-1362.

Background  Most patients with acute rheumatic fever report no antecedent pharyngitis.

Objective  To determine the clinical and microbiological characteristics of recurrent group A {beta}-hemolytic streptococcal (GABHS) tonsillopharyngitis.

Design  Prospective randomized trial.

Subjects  Symptoms were recorded and throat cultures were obtained at 4 to 6, 18 to 21, and 32 to 35 days following the start of treatment. A subset of 60 patients with subsequent GABHS episodes occurring were evaluated for a 0.2-or greater log rise in either antistreptolysin O or anti–deoxyribonuclease B titer to confirm a bona fide recurrence.

Results  Sixteen (27%) of 60 patients had recurrent GABHS tonsillopharyngitis of the same serotype that occurred 21 days or longer following the onset of the initial GABHS infection and was associated with a 0.2- or greater log rise in either antistreptolysin O or anti–deoxyribonuclease B titer, indicating bona fide recurrent infection; these recurrences all occurred within 55 days. Fewer patients with recurrent GABHS pharyngitis of the same serotype had headache (P = .02), sore throat (P = .006), fever (P = .008), pharyngeal erythema (P<.001), pharyngeal edema (P<.001), pharyngeal exudate (P = .04), and adenitis (P = .03) compared with the initial episode. Chills, stomachache, scarlatina, tonsillar enlargement, and palatal petechiae were similar for both episodes.

Conclusions  Fewer symptoms occur during recurrent GABHS pharyngitis of the same serotype compared with the initial infection. These patients may be less likely to seek physician attention, yet their infections put them at risk for sequelae.


From the Food and Drug Administration, Rockville, Md (Dr Lee); the Department of Pediatrics, University of Florida, Gainesville (Dr Ayoub); and the Department of Microbiology and Immunology, University of Rochester Medical Center, Rochester, NY (Dr Pichichero).


RELATED ARTICLE

Archives of Otolaryngology–Head & Neck Surgery Reader's Choice: Continuing Medical Education
Arch Otolaryngol Head Neck Surg. 2000;126(11):1400-1401.
FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Symptomatic Relapse of Group A {beta}-Hemolytic Streptococcal Tonsillopharyngitis in Children
Casey and Pichichero
CLIN PEDIATR 2007;46:307-310.
ABSTRACT  

Selecting the Optimal Antibiotic in the Treatment of Group A {beta}-Hemolytic Streptococci Pharyngitis
Casey
CLIN PEDIATR 2007;46:25S-35S.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2000 American Medical Association. All Rights Reserved.